Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03842007 · ClinicalTrials.gov registry record · NA
Understanding Mechanisms of Normal and Disordered Defecation
A NA study of Constipation, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 160
- Enrollment target
- 1
- Study location
NCT03842007: Recruiting NA study of Constipation, sponsored by Mayo Clinic.
NCT03842007 is a NA study of Constipation that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 160 participants, below the 202-participant average among 54 other Constipation trials with a reported enrollment target (21% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03842007, a NA study of Constipation, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
Researchers are trying to better understand why constipation occurs and improve the tests for diagnosing these conditions.
Primary Outcome
Measured by fecomanoflowmetry calculating the mean and maximum flow rate in various conditions (mg/sec), defecated volume (mg), flow time (sec) and time to maximum flow (sec). The amount of artificial stool evacuated is expressed in milligrams. The duration is in seconds. These 2 metrics are integrated to measure mg evacuated/second.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Rectal Barostat Study
- DIAGNOSTIC_TEST Fecoflowmetry
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2019-01-29 |
| Est. Completion | 2026-06 |
| Phase | NA |
What NCT03842007 shows while recruiting
NCT03842007 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 202-participant average among 54 other Constipation trials with a reported enrollment target (21% lower).
The record links to 1 condition, with Constipation appearing as the primary indexed condition, and to 2 interventions - of which Rectal Barostat Study is the first listed.
NCT03842007 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT03842007 about?
NCT03842007 is a clinical study titled "Understanding Mechanisms of Normal and Disordered Defecation". Researchers are trying to better understand why constipation occurs and improve the tests for diagnosing these conditions.
What is the current status of trial NCT03842007?
This trial is currently recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2019-01-29. Estimated completion is 2026-06.
What conditions does trial NCT03842007 study?
This clinical trial studies the following conditions: Constipation.
What interventions are being tested in trial NCT03842007?
The interventions under investigation include: Rectal Barostat Study (DIAGNOSTIC_TEST), Fecoflowmetry (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03842007?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03842007 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Constipation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03842007's enrollment target sits among peer trials
160 11th of 54 higher than 44 of 54 other Constipation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Constipation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Optimization of Postoperative Bowel Habits
RECRUITING · NA
-
Management of Dyssynergic Defecation
RECRUITING · NA
-
Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis
RECRUITING · NA
-
Fecobionics in Biofeedback Therapy in Dyssynergia Patients
RECRUITING · NA
-
Impact of Weizmannia (Bacillus) Coagulans JBI-YZ6.3 on Gut Health and Fecal Microbiome Changes
RECRUITING · NA
-
Impact of the Inno Cleanse Dietary Supplement on Gut Health and Associated Variables in Healthy Men and Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI